Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Zanamivir-resistant influenza viruses with a novel neuraminidase mutation.

Journal of virology - 1 Oct 2009

Hurt Aeron C, Holien Jessica K, Parker Michael, Kelso Anne, Barr Ian G

Abstract excerpt

The neuraminidase inhibitors zanamivir and oseltamivir are marketed for the treatment and prophylaxis of influenza and have been stockpiled by many countries for use in a pandemic. Although recent surveillance has identified a striking increase in the frequency of oseltamivir-resistant seasonal influenza A (H1N1) viruses in Europe, the United States, Oceania, and South Africa, to date there have been no reports...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Asia, Southeastern
Share to Ferrets
Share to Influenza A Virus, H1N1 Subtype

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Influenza, Human

Share to Neuraminidase

Share to Orthomyxoviridae Infections

Share to Oseltamivir

Share to Zanamivir

Source

Open in PubMed Open full text

Identifiers

PMID: 19641000
DOI: 10.1128/JVI.01200-09
PMCID: PMC2753113

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Zanamivir-resistant influenza viruses with a novel neuraminidase mutation.PMID 19641000Read ↗

Neuraminidase inhibitor resistance in influenza: a clinical perspectiveSemantic proximity Read ↗

Surveillance for Neuraminidase Inhibitor Resistance among Human Influenza A and B Viruses Circulating Worldwide from 2004 to 2008Semantic proximity Read ↗

Mutations of neuraminidase implicated in neuraminidase inhibitors resistance.Semantic proximity Read ↗

Oseltamivir-resistant influenza viruses circulating during the first year of the influenza A(H1N1) 2009 pandemic in the Asia-Pacific region, March 2009 to March 2010.Semantic proximity Read ↗

Detection and management of antiviral resistance for influenza virusesSemantic proximity Read ↗

Detection of Resistance Mutations to Antivirals Oseltamivir and Zanamivir in Avian Influenza A Viruses Isolated from Wild BirdsSemantic proximity Read ↗

Replacement of neuraminidase inhibitor-susceptible influenza A(H1N1) with resistant phenotype in 2008 and circulation of susceptible influenza A and B viruses during 2009-2013, South Africa.Semantic proximity Read ↗

Virus susceptibility analyses from a phase IV clinical trial of inhaled zanamivir treatment in children infected with influenza.Semantic proximity Read ↗

Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistanceSemantic proximity Read ↗

Characterization of oseltamivir-resistant 2009 H1N1 pandemic influenza A viruses.Semantic proximity Read ↗

Pandemic 2009 H1N1 Influenza A Virus Carrying a Q136K Mutation in the Neuraminidase Gene Is Resistant to Zanamivir but Exhibits Reduced Fitness in the Guinea Pig Transmission ModelSemantic proximity Read ↗

Influenza virus susceptibility and resistance to oseltamivir.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.